AMZN
Amazon.com, Inc.
AMZN has the edge over BJRI overall, supported by stronger modeled upside and lower modeled downside.
BJRI
BJ's Restaurants, Inc.
BJRI offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BJRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
BJRI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BJRI in the historical PE scenario, which offers more potential upside but is not a forecast.
BJRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $42.55 | -22% |
| Current | 26x | $54.89 | — |
| Fair | 32x | $66.37 | +21% |
| Expensive | 51x | $108 | +96% |
Historical ranges are pointers, not guarantees.
BJRI's PE is in its cheap range at 26x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BJRI Forward outlook
There aren't enough analyst estimates for BJRI to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BJRI on earnings, with more consistent year-over-year improvement.
BJRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.10 | +54% |
| Q2 2026 | $1.88 | +55% |
| Q1 2026 | $1.99 | +107% |
| Q4 2025 | $2.16 | +209% |
| Q3 2025 | $1.36 | +9.7% |
| Q2 2025 | $1.21 | 0% |
| Q1 2025 | $0.96 | -3% |
| Q4 2024 | $0.70 | -15% |
BJRI earned $2.10 per share over the past year, up 54% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BJRI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BJRI on profitability, with a higher operating margin.
BJRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $358.6M | +8.6% |
| Q2 2026 | $388.9M | +6.4% |
| Q1 2026 | $358.1M | +2.9% |
| Q4 2025 | $355.4M | +3.2% |
| Q3 2025 | $330.2M | +1.4% |
| Q2 2025 | $365.6M | +4.5% |
| Q1 2025 | $348M | +3.2% |
| Q4 2024 | $344.3M | +6.4% |
BJRI's revenue has grown year over year for 10 quarters in a row: $359M last quarter, up 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +1.8 points |
| Q2 2026 | 4.7% | -1.1 points |
| Q1 2026 | 3% | -1.3 points |
| Q4 2025 | 3.1% | +4.5 points |
| Q3 2025 | -0.3% | +0.5 points |
| Q2 2025 | 5.8% | +2 points |
| Q1 2025 | 4.3% | +1.8 points |
| Q4 2024 | -1.4% | -2.4 points |
BJRI's operating margin was 1.5% last quarter, up 1.8 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BJRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.2M | +515% |
| Q2 2026 | $7.7M | -82% |
| Q1 2026 | $27.2M | +$39.2M |
| Q4 2025 | $7.5M | -53% |
| Q3 2025 | $3.6M | -53% |
| Q2 2025 | $41.9M | +5601% |
| Q1 2025 | -$12.1M | -2792% |
| Q4 2024 | $15.8M | +3.1% |
BJRI has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BJRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +693K shares |
| 1 year | +0.4% | +99K shares |
| 3 years | -4.1% | -960K shares |
| 5 years | -3% | -708K shares |
| Available history | +9.7% | +2M shares |
BJRI has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1M |
| Q2 2026 | $2.4M |
| Q1 2026 | $5.3M |
| Q4 2025 | $5.4M |
| Q3 2025 | $33.2M |
| Q2 2025 | $15.1M |
| Q1 2025 | $14.1M |
| Q4 2024 | $8M |
BJRI spent $14M buying back its own shares over the past year, down 80% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BJRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 0.5x | Very low |
BJRI has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BJRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 16.3 | Oversold |
BJRI's weekly RSI is 47 (neutral) and its Stochastic is 16 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over BJRI on valuation relative to its sector.
BJRI PE vs Consumer Cyclical Sector
| Metric | BJRI | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 45% above |
| PE % | 27 | 47 | 20 pts below |
BJRI is trading at 26x earnings, a 45% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BJRI on trend strength, trading above more of its moving averages.
BJRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.9 | 6.7% below |
| 20 week MA | $62.2 | 12% below |
| 50 week MA | $49.9 | 10% above |
| 100 week MA | $43.1 | 27% above |
| 200 week MA | $37.7 | 46% above |
BJRI has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 46% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
BJRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.4 | $39.1 | +4.5% |
| 2021 | $39.1 | $36.1 | -7.6% |
| 2022 | $36.1 | $27.8 | -23% |
| 2023 | $27.8 | $36.0 | +30% |
| 2024 | $36.0 | $34.7 | -3.5% |
| 2025 | $34.7 | $41.2 | +19% |
| 2026 YTD | $41.2 | $54.9 | +33% |
BJRI has the edge over AMZN on returns for 2026, with the stronger performance.